FDA applicant
Neotract, Inc.
FDA records 17 decisions for Neotract, Inc. (Pleasanton, CA) from 2006 to 2023: 16 510(k) clearances and 1 De Novo grant. Most are in product codes PEW (Implantable Transprostatic Tissue Retractor…) and GAT (Suture, Nonabsorbable, Synthetic, Polyethylene). Its devices cite 20 predicates, 16 of them its own earlier devices. 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Neotract, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
1in 2022
Class I Class II/III not classified
Planning a device like Neotract, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report